NYSE:DPLO - Diplomat Pharmacy Stock Price, News, & Analysis

Diplomat Pharmacy trades on the New York Stock Exchange (NYSE) under the ticker symbol "DPLO."

Diplomat Pharmacy Inc (NYSE:DPLO) announced its earnings results on Tuesday, November, 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.22 by $0.21. The company earned $1.37 billion during the quarter, compared to the consensus estimate of $1.42 billion. Diplomat Pharmacy had a net margin of 0.04% and a return on equity of 5.31%. The business's quarterly revenue was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.01 EPS. View Diplomat Pharmacy's Earnings History.

Diplomat Pharmacy is scheduled to release their next quarterly earnings announcement on Monday, February 25th 2019. View Earnings Estimates for Diplomat Pharmacy.

Diplomat Pharmacy updated its FY 2018 earnings guidance on Monday, January, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $5.5-5.6 billion, compared to the consensus revenue estimate of $5.56 billion.

12 analysts have issued twelve-month price objectives for Diplomat Pharmacy's stock. Their forecasts range from $15.00 to $33.00. On average, they expect Diplomat Pharmacy's stock price to reach $22.70 in the next year. This suggests a possible upside of 68.3% from the stock's current price. View Analyst Price Targets for Diplomat Pharmacy.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diplomat Pharmacy in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Diplomat Pharmacy.

Media coverage about DPLO stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Diplomat Pharmacy earned a coverage optimism score of 0.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Some companies that are related to Diplomat Pharmacy include Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Diplomat Pharmacy's stock is owned by many different of institutional and retail investors. Top institutional investors include Louisiana State Employees Retirement System (0.03%) and Fox Run Management L.L.C. (0.02%). Company insiders that own Diplomat Pharmacy stock include Atul Kavthekar, Jeffrey G Park, Joel Saban, Philip R Hagerman and Shawn Tomasello. View Institutional Ownership Trends for Diplomat Pharmacy.

DPLO stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System. Company insiders that have sold Diplomat Pharmacy company stock in the last year include Jeffrey G Park, Philip R Hagerman and Shawn Tomasello. View Insider Buying and Selling for Diplomat Pharmacy.

DPLO stock was purchased by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C.. Company insiders that have bought Diplomat Pharmacy stock in the last two years include Atul Kavthekar, Jeffrey G Park and Joel Saban. View Insider Buying and Selling for Diplomat Pharmacy.

Shares of DPLO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DPLO stock can currently be purchased for approximately $13.49.

Diplomat Pharmacy has a market capitalization of $1.00 billion and generates $4.49 billion in revenue each year. The company earns $15.51 million in net income (profit) each year or $0.84 on an earnings per share basis. Diplomat Pharmacy employs 2,419 workers across the globe.

The official website for Diplomat Pharmacy is http://www.diplomatpharmacy.com.

Diplomat Pharmacy's mailing address is 4100 S. SAGINAW ST., FLINT MI, 48507. The company can be reached via phone at 888-720-4450 or via email at [email protected]